| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | George Karakiulakis | |
| Eleni Papakonstantinou | |||
| P2860 | cites work | Human aggrecan keratan sulfate undergoes structural changes during adolescent development | Q77359731 |
| Hyaluronan fragments synergize with interferon-gamma to induce the C-X-C chemokines mig and interferon-inducible protein-10 in mouse macrophages | Q77696816 | ||
| The relationship between the structure of dermatan sulfate derivatives and their antithrombotic activities | Q79347338 | ||
| Analysis of plasma proteins that bind to glycosaminoglycans | Q79440936 | ||
| In vivo stimulation of de novo collagen production caused by cross-linked hyaluronic acid dermal filler injections in photodamaged human skin | Q79798736 | ||
| Interaction of interleukin-6 and the BMP pathway in pulmonary smooth muscle | Q79830429 | ||
| Effect of heparin on blood vascular endothelial growth factor levels in patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention | Q80333439 | ||
| A synthetic conjugate polysaccharide vaccine against Haemophilus influenzae type b | Q80378109 | ||
| Proteinuria-lowering effect of heparin therapy in diabetic nephropathy without affecting the renin-angiotensin-aldosterone system | Q80797255 | ||
| Effects of dermatan sulfate for anticoagulation in continuous renal replacement therapy | Q81186635 | ||
| Heparanase prevents the development of type 1 diabetes in non-obese diabetic mice by regulating T-cell activation and cytokines production | Q81473187 | ||
| DisCoVisc versus the soft-shell technique using Viscoat and Provisc in phacoemulsification: randomized clinical trial | Q81501600 | ||
| Deciphering the "matrix" in pulmonary vascular remodelling | Q81702646 | ||
| Intravesical glycosaminoglycan replenishment with chondroitin sulphate in chronic forms of cystitis. A multi-national, multi-centre, prospective observational clinical trial | Q81885943 | ||
| Increased hyaluronic acid content in idiopathic pulmonary arterial hypertension | Q81924633 | ||
| Effect of intra-articular injection of hyaluronic acid in rheumatoid arthritis patients with knee osteoarthritis | Q81931323 | ||
| Safety and efficacy of intra-articular sodium hyaluronate (Hyalgan) in a randomized, double-blind study for osteoarthritis of the ankle | Q81953216 | ||
| The glycosaminoglycan attachment regions of human aggrecan | Q83297890 | ||
| Clasps are CLIP-115 and -170 associating proteins involved in the regional regulation of microtubule dynamics in motile fibroblasts | Q24291093 | ||
| A hyaluronidase activity of the sperm plasma membrane protein PH-20 enables sperm to penetrate the cumulus cell layer surrounding the egg | Q24315823 | ||
| Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1 | Q24317667 | ||
| There are two major types of skeletal keratan sulphates | Q24529530 | ||
| Regulatory and signaling properties of the Vav family | Q24554307 | ||
| Keratan sulfate biosynthesis | Q24608330 | ||
| Contaminated heparin associated with adverse clinical events and activation of the contact system | Q24619723 | ||
| Hyaluronan and the hyaluronan receptor RHAMM promote focal adhesion turnover and transient tyrosine kinase activity | Q24651389 | ||
| CD44 interaction with c-Src kinase promotes cortactin-mediated cytoskeleton function and hyaluronic acid-dependent ovarian tumor cell migration | Q28116092 | ||
| Role of transforming growth factor beta in human disease | Q28143408 | ||
| The intracellular hyaluronan receptor RHAMM/IHABP interacts with microtubules and actin filaments | Q28146159 | ||
| CD44 in cancer | Q28217782 | ||
| Tumor cell interactions with the extracellular matrix during invasion and metastasis | Q28258256 | ||
| Matrix proteoglycans: from molecular design to cellular function | Q28284300 | ||
| Identification of an O-glycosidic mannose-linked sialylated tetrasaccharide and keratan sulfate oligosaccharides in the chondroitin sulfate proteoglycan of brain | Q28285133 | ||
| Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation | Q28296150 | ||
| Chemical change involved in the oxidative reductive depolymerization of hyaluronic acid | Q28334887 | ||
| The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activation | Q28360727 | ||
| Resolution of lung inflammation by CD44 | Q28506254 | ||
| Molecular cloning and characterization of an N-acetylglucosamine-6-O-sulfotransferase | Q28510283 | ||
| ADAMTS7B, the full-length product of the ADAMTS7 gene, is a chondroitin sulfate proteoglycan containing a mucin domain | Q28512997 | ||
| The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted | Q28567772 | ||
| Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties | Q28585737 | ||
| Two faces of chondroitin sulfate proteoglycan in spinal cord repair: a role in microglia/macrophage activation | Q28757375 | ||
| Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor | Q29616189 | ||
| Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry | Q29618605 | ||
| Heparan sulphate proteoglycans fine-tune mammalian physiology | Q29619329 | ||
| Heparin-II domain of fibronectin is a vascular endothelial growth factor-binding domain: enhancement of VEGF biological activity by a singular growth factor/matrix protein synergism | Q30504482 | ||
| Differential degradation of matrix proteoglycans and edema development in rabbit lung | Q33224907 | ||
| Structure-activity studies of heparan mimetic polyanions for anti-prion therapies | Q33297991 | ||
| Clinical review of chondroitin sulfate in osteoarthritis | Q33357124 | ||
| Leukocytic cell sources of airway tissue kallikrein | Q37115098 | ||
| Chondroitin sulphate for symptomatic osteoarthritis: critical appraisal of meta-analyses | Q37139848 | ||
| Involvement of highly sulfated chondroitin sulfate in the metastasis of the Lewis lung carcinoma cells | Q37142788 | ||
| Progress in the development of matrix metalloproteinase inhibitors | Q37184951 | ||
| Anti-inflammatory activity of chondroitin sulfate | Q37230656 | ||
| Intra-articular use of hyaluronic acid in the treatment of osteoarthritis | Q37237700 | ||
| Hyaluronan as an ophthalmic viscoelastic device | Q37239801 | ||
| The role of hyaluronan synthase 3 in ventilator-induced lung injury. | Q37282731 | ||
| CD44-related chondroitin sulfate proteoglycan, a cell surface receptor implicated with tumor cell invasion, mediates endothelial cell migration on fibrinogen and invasion into a fibrin matrix | Q37355709 | ||
| Enzymic pathways of hyaluronan catabolism | Q38258587 | ||
| Serum keratan sulfate transiently increases in the early stage of osteoarthritis during strenuous running of rats: protective effect of intraarticular hyaluronan injection. | Q38274507 | ||
| Oligosaccharide sequence of human breast cancer cell heparan sulfate with high affinity for laminin | Q38334650 | ||
| Characterization of an N-acetylglucosamine-6-O-sulfotransferase from human respiratory mucosa active on mucin carbohydrate chains. | Q38341349 | ||
| Biosynthesis of keratan sulfate: Purification and properties of a galactosyltransferase from bovine cornea | Q39246092 | ||
| Chronic interstitial pulmonary fibrosis produced in hamsters by endotracheal bleomycin. Lung volumes, volume-pressure relations, carbon monoxide uptake, and arterial blood gas studied | Q39482869 | ||
| Proteoglycans in health and disease: structures and functions | Q39750946 | ||
| Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. | Q39774105 | ||
| Function of heparanase in prostate tumorigenesis: potential for therapy | Q40021877 | ||
| Hyaluronan oligosaccharides sensitize lymphoma resistant cell lines to vincristine by modulating P-glycoprotein activity and PI3K/Akt pathway. | Q40055795 | ||
| Chondroitinase ABC promotes corticospinal axon growth in organotypic cocultures | Q40082752 | ||
| Hyaluronan and the interaction between CD44 and epidermal growth factor receptor in oncogenic signaling and chemotherapy resistance in head and neck cancer | Q40254662 | ||
| Growth factor- and heparin-dependent regulation of constitutive and agonist-mediated human endothelial barrier function | Q40282850 | ||
| Chondroitin sulfate B and heparin mediate adhesion of Penicillium marneffei conidia to host extracellular matrices | Q40321475 | ||
| Involvement of glycosaminoglycans in the attachment of pneumococci to nasopharyngeal epithelial cells. | Q40359764 | ||
| Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression. | Q40396971 | ||
| Therapeutic uses of heparin beyond its traditional role as an anticoagulant | Q40469896 | ||
| A 12-case series of Penicillium marneffei pneumonia. | Q40479342 | ||
| Dermatan sulfate exerts an enhanced growth factor response on skeletal muscle satellite cell proliferation and migration | Q40619052 | ||
| Increased in vitro cytotoxicity of TNF-alpha analog LK-805 is based on the interaction with cell surface heparan sulfate proteoglycan | Q40683154 | ||
| NF-kappa B activation mediates the cross-talk between extracellular matrix and interferon-gamma (IFN-gamma) leading to enhanced monokine induced by IFN-gamma (MIG) expression in macrophages | Q40704641 | ||
| Characterization of the heparin-binding properties of IL-6. | Q40843935 | ||
| Regulation of plasminogen activator inhibitor-1 and urokinase by hyaluronan fragments in mouse macrophages | Q40853251 | ||
| Heparin differentially regulates the interaction of fibroblast growth factor-4 with FGF receptors 1 and 2. | Q40924743 | ||
| Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses | Q40925991 | ||
| Induction and regulation of macrophage metalloelastase by hyaluronan fragments in mouse macrophages. | Q40960851 | ||
| Interleukin-5 binds to heparin/heparan sulfate. A model for an interaction with extracellular matrix | Q41058692 | ||
| Hyaluronan fragments induce nitric-oxide synthase in murine macrophages through a nuclear factor kappaB-dependent mechanism | Q41120284 | ||
| The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for pro-gelatinase A activation | Q41380842 | ||
| Variations in the Size and Sulfation of Heparin Modulate the Effect of Heparin on the Binding of VEGF165 to Its Receptors | Q41442399 | ||
| Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity | Q41489951 | ||
| Hyaluronan synthases | Q41517952 | ||
| Dynamic role of hyaluronan (HYA) in connective tissue activation and inflammation | Q41566287 | ||
| Proteoglycans: the "Teflon" of the airways? | Q41665467 | ||
| Identification of glycosaminoglycans in human airway secretions. | Q42050150 | ||
| Cell surface chondroitin sulfate glycosaminoglycan in melanoma: role in the activation of pro-MMP-2 (pro-gelatinase A). | Q42776385 | ||
| Highly sensitive sequencing of the sulfated domains of heparan sulfate. | Q42814375 | ||
| A model of synovial fluid lubricant composition in normal and injured joints. | Q43471835 | ||
| Transcriptional regulation and function during the human cell cycle | Q43515454 | ||
| Binding of heparan sulfate to type V collagen. A mechanism of cell-substrate adhesion. | Q43541192 | ||
| Airway smooth muscle cell proliferation is increased in asthma | Q43704206 | ||
| Hypoxia differentially enhances the effects of transforming growth factor-beta isoforms on the synthesis and secretion of glycosaminoglycans by human lung fibroblasts | Q44002276 | ||
| Low molecular weight hyaluronan from stretched lung enhances interleukin-8 expression. | Q44435133 | ||
| Structure, strength, failure, and remodeling of the pulmonary blood-gas barrier | Q33547255 | ||
| Dermatan sulfate activates nuclear factor-kappab and induces endothelial and circulating intercellular adhesion molecule-1. | Q33851916 | ||
| Platelet-derived growth factor stimulates the secretion of hyaluronic acid by proliferating human vascular smooth muscle cells | Q33876874 | ||
| Neointimal macrophages colocalize with extracellular matrix gene expression in human atherosclerotic pulmonary arteries | Q33890640 | ||
| Clinical manifestations in a large hereditary hemorrhagic telangiectasia (HHT) type 2 kindred | Q34006402 | ||
| BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension | Q34043809 | ||
| Balancing thymocyte adhesion and motility: a functional linkage between beta1 integrins and the motility receptor RHAMM. | Q34092937 | ||
| Pathogenesis of pneumococcal infection | Q34113380 | ||
| Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene | Q34142690 | ||
| Sulfotransferases in glycosaminoglycan biosynthesis | Q34271228 | ||
| Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate | Q34271235 | ||
| TGF-beta in the cardiovascular system: molecular mechanisms of a context-specific growth factor | Q34294254 | ||
| Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in a large kindred | Q34325667 | ||
| Role of heparan sulfate domain organization in endostatin inhibition of endothelial cell function | Q34361094 | ||
| Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. | Q34381015 | ||
| Pathobiology of pulmonary hypertension. Extracellular matrix | Q34394967 | ||
| The sweet and sour of cancer: glycans as novel therapeutic targets | Q34439560 | ||
| Hyaluronan and homeostasis: a balancing act. | Q34444922 | ||
| Signaling properties of hyaluronan receptors | Q34444928 | ||
| Regulation of lung injury and repair by Toll-like receptors and hyaluronan | Q34462186 | ||
| Cellular pathophysiology and therapy of pulmonary hypertension. | Q34468643 | ||
| Heparin sequences in the heparan sulfate chains of an endothelial cell proteoglycan | Q34626210 | ||
| Mammalian hyaluronan synthases | Q35038976 | ||
| S100A4/Mts1 produces murine pulmonary artery changes resembling plexogenic arteriopathy and is increased in human plexogenic arteriopathy | Q35083293 | ||
| Hyaluronan in Respiratory Injury and Repair | Q35114619 | ||
| Enhanced levels of hyaluronan in lungs of patients with COPD: relationship with lung function and local inflammation | Q35537464 | ||
| Devising a pathway for hyaluronan catabolism: are we there yet? | Q35545694 | ||
| Migration of bovine aortic smooth muscle cells after wounding injury. The role of hyaluronan and RHAMM | Q35553227 | ||
| Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family | Q35559673 | ||
| Bench-to-bedside review: the role of glycosaminoglycans in respiratory disease | Q35629808 | ||
| Protective role of activated protein C in lung and airway remodeling. | Q35760633 | ||
| Tenascin-C, proliferation and subendothelial fibronectin in progressive pulmonary vascular disease. | Q35764350 | ||
| Pulmonary artery adventitial changes and venous involvement in primary pulmonary hypertension. | Q35796205 | ||
| Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. | Q44756938 | ||
| Intracellular hyaluronan in arterial smooth muscle cells: association with microtubules, RHAMM, and the mitotic spindle | Q44906580 | ||
| Hyaluronan decreases surfactant inactivation in vitro | Q45178545 | ||
| Overexpression of hyaluronan in the tunica media promotes the development of atherosclerosis | Q45261400 | ||
| Decreased hyaluronan in airway smooth muscle cells from patients with asthma and COPD. | Q46090444 | ||
| Localization of vascular response to VEGF is not dependent on heparin binding | Q46147238 | ||
| Elevation of tissue kallikrein and kinin in the airways of asthmatic subjects after endobronchial allergen challenge | Q46215578 | ||
| Regulation of MDR1 expression and drug resistance by a positive feedback loop involving hyaluronan, phosphoinositide 3-kinase, and ErbB2. | Q46398274 | ||
| Characterization of total plasma glycosaminoglycan levels in healthy volunteers following oral administration of a novel antithrombotic odiparcil with aspirin or enoxaparin | Q46403531 | ||
| Chondroitin-4-sulphate inhibits NF-kB translocation and caspase activation in collagen-induced arthritis in mice | Q46576967 | ||
| Chondroitin-4-sulphate reduced oxidative injury in caerulein-induced pancreatitis in mice: the involvement of NF-kappaB translocation and apoptosis activation | Q46648129 | ||
| Inhaled hyaluronic acid against exercise-induced bronchoconstriction in asthma | Q46684891 | ||
| Endothelial heparan sulfate deficiency impairs L-selectin- and chemokine-mediated neutrophil trafficking during inflammatory responses | Q46806608 | ||
| Inhaled porcine pancreatic elastase causes bronchoconstriction via a bradykinin-mediated mechanism | Q46811457 | ||
| Mammalian expression of full-length bovine aggrecan and link protein: formation of recombinant proteoglycan aggregates and analysis of proteolytic cleavage by ADAMTS-4 and MMP-13. | Q46904435 | ||
| Nonpenetrating deep sclerectomy with reticulated hyaluronic acid implant versus punch trabeculectomy: a prospective clinical trial | Q47300827 | ||
| Aerosolised hyaluronic acid prevents exercise-induced bronchoconstriction, suggesting novel hypotheses on the correction of matrix defects in asthma | Q47657047 | ||
| Positive end-expiratory pressure prevents lung mechanical stress caused by recruitment/derecruitment | Q47924977 | ||
| A 340 kDa hyaluronic acid secreted by human vascular smooth muscle cells regulates their proliferation and migration | Q47929146 | ||
| Anti-inflammatory function of an in situ cross-linkable conjugate hydrogel of hyaluronic acid and dexamethasone. | Q51088732 | ||
| Results of endovesical hyaluronic acid/chondroitin sulfate in the treatment of Interstitial Cystitis/Painful Bladder Syndrome. | Q51702662 | ||
| Effect of Salbutamol, Fenoterol, and Sodium Cromoglycate on the Release of Heparin from Sensitized Human Lung Fragments Challenged with Dermatophagoides pteronyssinus Allergen | Q53748838 | ||
| Hyaluronic acid blocks porcine pancreatic elastase (PPE)-induced bronchoconstriction in sheep. | Q53986517 | ||
| Interstitial cystitis: bladder pain and beyond | Q56908908 | ||
| CX3C Chemokine Fractalkine in Pulmonary Arterial Hypertension | Q59124781 | ||
| Cell type-specific effect of hypoxia and platelet-derived growth factor-BB on extracellular matrix turnover and its consequences for lung remodeling. | Q64914239 | ||
| Comparison of cyclic GMP in human internal mammary artery and saphenous vein: implications for coronary artery bypass graft patency | Q67544986 | ||
| A novel sulfated structure in the carbohydrate-protein linkage region isolated from porcine intestinal heparin | Q67728340 | ||
| Collagen synthesis and degradation in vivo. Evidence for rapid rates of collagen turnover with extensive degradation of newly synthesized collagen in tissues of the adult rat | Q68826766 | ||
| Concentrations of glandular kallikrein in human nasal secretions increase during experimentally induced allergic rhinitis | Q69303796 | ||
| The distribution of the glycosaminoglycans in the anatomic components of the lung and the changes in concentration of these macromolecules during development and aging | Q70394263 | ||
| Preventing bronchoconstriction in exercise-induced asthma with inhaled heparin | Q70759509 | ||
| Subcutaneous administration of hyaluronan reduces the number of infectious exacerbations in patients with chronic bronchitis | Q70838970 | ||
| Time course of the protective effect of inhaled heparin on exercise-induced asthma | Q71078933 | ||
| Glycosaminoglycan and collagen synthesis in N-nitroso-N-methylurethane induced pulmonary fibrosis | Q71502338 | ||
| Effects of bradykinin on renal lymph flow and composition | Q71713518 | ||
| Hyaluronan (HYAL-BV 5200) inhibits neo-intimal macrophage influx after balloon-catheter induced injury in the cholesterol-fed rabbit | Q71858789 | ||
| The control of adrenocortical cytodifferentiation by extracellular matrix | Q72875712 | ||
| Activation and transforming growth factor-beta production in eosinophils by hyaluronan | Q73038084 | ||
| Expression of hyaluronan receptors CD44 and RHAMM in stomach cancers: relevance with tumor progression | Q73072089 | ||
| Hypoxia modifies the effect of PDGF on glycosaminoglycan synthesis by primary human lung cells | Q73127443 | ||
| Bronchial tissue kallikrein activity is regulated by hyaluronic acid binding | Q73205578 | ||
| CD44 is the principal mediator of hyaluronic-acid-induced melanoma cell proliferation | Q73419466 | ||
| Irradiation-induced expression of hyaluronan (HA) synthase 2 and hyaluronidase 2 genes in rat lung tissue accompanies active turnover of HA and induction of types I and III collagen gene expression | Q74259168 | ||
| Regulation of hyaluronan-induced chemokine gene expression by IL-10 and IFN-gamma in mouse macrophages | Q74336649 | ||
| The effect of hyaluronan on elastic fiber injury in vitro and elastase-induced airspace enlargement in vivo | Q74347281 | ||
| The pattern of expression of the microtubule-binding protein RHAMM/IHABP in mammary carcinoma suggests a role in the invasive behaviour of tumour cells | Q74602373 | ||
| Primary pulmonary hypertension | Q77206721 | ||
| Cellular and molecular pathobiology of pulmonary arterial hypertension | Q35803229 | ||
| Hyaluronan: from extracellular glue to pericellular cue. | Q35824079 | ||
| The regulated synthesis of versican, decorin, and biglycan: extracellular matrix proteoglycans that influence cellular phenotype | Q35833847 | ||
| Treatment of pulmonary arterial hypertension | Q35905944 | ||
| Drug treatment of pneumococcal pneumonia in the elderly | Q35922763 | ||
| Structural insights into biological roles of protein-glycosaminoglycan interactions | Q36083300 | ||
| Biomechanics of the lung parenchyma: critical roles of collagen and mechanical forces | Q36097622 | ||
| Structure and biological activity of heparinoid | Q36126789 | ||
| Regulation of protein function by glycosaminoglycans--as exemplified by chemokines | Q36161167 | ||
| Interaction of chemokines and glycosaminoglycans: a new twist in the regulation of chemokine function with opportunities for therapeutic intervention | Q36180251 | ||
| Heparan sulfate: a complex polymer charged with biological activity | Q36190979 | ||
| Hyaluronan metabolism: a major paradox in cancer biology | Q36221125 | ||
| Supramolecular organization of extracellular matrix glycosaminoglycans, in vitro and in the tissues | Q36240924 | ||
| Microtubule targeting of substrate contacts promotes their relaxation and dissociation | Q36316658 | ||
| Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. | Q36376473 | ||
| ADAMTS proteinases: potential therapeutic targets? | Q36393546 | ||
| Carbohydrate-based experimental therapeutics for cancer, HIV/AIDS and other diseases | Q36515536 | ||
| Matrix regulation of lung injury, inflammation, and repair: the role of innate immunity | Q36518585 | ||
| Remodeling in asthma and chronic obstructive pulmonary disease | Q36518612 | ||
| Hyaluronans: is clinical effectiveness dependent on molecular weight? | Q36621798 | ||
| Hyaluronan-mediated angiogenesis in vascular disease: uncovering RHAMM and CD44 receptor signaling pathways | Q36630402 | ||
| Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted | Q36712749 | ||
| Molecular pathogenesis of pulmonary arterial hypertension | Q36736065 | ||
| Effect of chondroitin sulphate in a rabbit model of atherosclerosis aggravated by chronic arthritis | Q36736328 | ||
| Syndecan-1 is an in vivo suppressor of Gram-positive toxic shock | Q36761832 | ||
| Leptospiral pneumonias | Q36783362 | ||
| Synthesis and medical applications of oligosaccharides | Q36802338 | ||
| Benefit of chondroitinase ABC on sensory axon regeneration in a laceration model of spinal cord injury in the rat | Q36823623 | ||
| Hyaluronan in tissue injury and repair | Q36824173 | ||
| Hyaluronan: a constitutive regulator of chemoresistance and malignancy in cancer cells | Q36839505 | ||
| Regulation of matrix turnover: fibroblasts, forces, factors and fibrosis. | Q36883818 | ||
| Transforming growth factor beta/bone morphogenic protein signaling in pulmonary arterial hypertension: remodeling revisited | Q37005379 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lung disease | Q3392853 |
| P304 | page(s) | 1111-1127 | |
| P577 | publication date | 2009-06-05 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | The 'sweet' and 'bitter' involvement of glycosaminoglycans in lung diseases: pharmacotherapeutic relevance | |
| P478 | volume | 157 |
| Q61444743 | A cationic near infrared fluorescent agent and ethyl-cinnamate tissue clearing protocol for vascular staining and imaging |
| Q34295275 | A comparative study of matrix remodeling in chronic models for COPD; mechanistic insights into the role of TNF-α. |
| Q35347946 | Cigarette smoke extract induces a phenotypic shift in epithelial cells; involvement of HIF1α in mesenchymal transition. |
| Q33806763 | Endothelial and leukocyte heparan sulfates regulate the development of allergen-induced airway remodeling in a mouse model |
| Q34058642 | Evaluation of the ability of LL-37 to neutralise LPS in vitro and ex vivo. |
| Q61796438 | Expression, activity and localization of lysosomal sulfatases in Chronic Obstructive Pulmonary Disease |
| Q38262619 | Extracellular matrix as a driver for lung regeneration |
| Q37834449 | Fibrotic response of tissue remodeling in COPD. |
| Q36361216 | Glycosaminoglycans are involved in bacterial adherence to lung cells. |
| Q36466209 | Hyaluronan Rafts on Airway Epithelial Cells |
| Q35370946 | Hyaluronan fragments as mediators of inflammation in allergic pulmonary disease |
| Q35637833 | Hyaluronan stimulates ex vivo B lymphocyte chemotaxis and cytokine production in a murine model of fungal allergic asthma |
| Q39300315 | Hyaluronic acid: A key molecule in skin aging |
| Q90020815 | Idiopathic pulmonary fibrosis and pulmonary hypertension: Heracles meets the Hydra |
| Q51035245 | Infrared irradiation alters the expression of matrix metalloproteinases and glycosaminoglycans in the cornea and crystalline lens. |
| Q38688645 | Inhibition of Hyaluronan Synthesis Attenuates Pulmonary Hypertension Associated with Lung Fibrosis. |
| Q37330296 | Is GERD a Factor in Osteonecrosis of the Jaw? Evidence of Pathology Linked to G6PD Deficiency and Sulfomucins |
| Q35688264 | Mechanobiology in lung epithelial cells: measurements, perturbations, and responses |
| Q36440308 | Muscarinic receptors and their antagonists in COPD: anti-inflammatory and antiremodeling effects |
| Q46247136 | One-pot analysis of sulfated glycosaminoglycans |
| Q38117343 | Plastic bronchitis in patients with fontan physiology: review of the literature and preliminary experience with fontan conversion and cardiac transplantation |
| Q36338544 | Production of decellularized porcine lung scaffolds for use in tissue engineering |
| Q41843692 | Pulmonary surfactant proteins and polymer combinations reduce surfactant inhibition by serum |
| Q88283038 | Regulation of eosinophil recruitment and allergic airway inflammation by heparan sulfate proteoglycan (HSPG) modifying enzymes |
| Q33747452 | Similar matrix alterations in alveolar and small airway walls of COPD patients |
| Q47662409 | Synthesized Heparan Sulfate Competitors Attenuate Pseudomonas aeruginosa Lung Infection. |
| Q36508659 | TSG-6 protein is crucial for the development of pulmonary hyaluronan deposition, eosinophilia, and airway hyperresponsiveness in a murine model of asthma |
| Q64104698 | Tissue Engineering: Understanding the Role of Biomaterials and Biophysical Forces on Cell Functionality Through Computational and Structural Biotechnology Analytical Methods |
Search more.